LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
LeMaitre Vascular (Nasdaq: LMAT) has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre Vascular (Nasdaq: LMAT) has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference. The company's management team is scheduled to deliver their presentation on Tuesday, April 8, 2025, at 3:45 PM EDT. This virtual event represents an opportunity for investors and healthcare industry stakeholders to gain insights into LeMaitre's operations and strategic initiatives.
Details
News Market Reaction – LMAT
The recorded move for LMAT in the trading session of this news was +1.50%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 smillar@lemaitre.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.